KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 101 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 1.43 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $1,422,000 | -67.5% | 418,255 | -64.1% | 0.00% | -100.0% |
| Q2 2018 | $4,379,000 | +172.2% | 1,164,421 | +196.2% | 0.00% | – |
| Q1 2018 | $1,609,000 | -5.2% | 393,106 | +7.7% | 0.00% | – |
| Q4 2017 | $1,698,000 | -46.5% | 365,148 | -18.3% | 0.00% | -100.0% |
| Q3 2017 | $3,172,000 | +19.9% | 446,734 | +22.1% | 0.00% | 0.0% |
| Q2 2017 | $2,646,000 | -50.2% | 365,999 | -57.6% | 0.00% | 0.0% |
| Q1 2017 | $5,312,000 | -0.9% | 862,362 | -5.7% | 0.00% | 0.0% |
| Q4 2016 | $5,358,000 | +552.6% | 914,200 | +491.0% | 0.00% | – |
| Q3 2016 | $821,000 | -47.9% | 154,697 | -35.0% | 0.00% | -100.0% |
| Q2 2016 | $1,575,000 | +186.4% | 237,930 | +102.2% | 0.00% | – |
| Q1 2016 | $550,000 | -35.6% | 117,669 | -30.5% | 0.00% | – |
| Q4 2015 | $854,000 | +59.3% | 169,255 | +11.1% | 0.00% | – |
| Q3 2015 | $536,000 | -72.1% | 152,279 | -20.7% | 0.00% | -100.0% |
| Q2 2015 | $1,918,000 | -19.4% | 192,115 | +2.7% | 0.00% | 0.0% |
| Q1 2015 | $2,381,000 | -38.3% | 187,015 | -31.4% | 0.00% | 0.0% |
| Q4 2014 | $3,859,000 | -36.0% | 272,685 | -37.8% | 0.00% | -50.0% |
| Q3 2014 | $6,031,000 | +73.7% | 438,597 | +94.2% | 0.00% | +100.0% |
| Q2 2014 | $3,473,000 | +12.9% | 225,860 | +25.1% | 0.00% | 0.0% |
| Q1 2014 | $3,076,000 | +79.5% | 180,527 | +36.4% | 0.00% | 0.0% |
| Q4 2013 | $1,714,000 | +35.5% | 132,329 | +5.6% | 0.00% | 0.0% |
| Q3 2013 | $1,265,000 | +24.8% | 125,356 | -7.7% | 0.00% | 0.0% |
| Q2 2013 | $1,014,000 | – | 135,777 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $3 | 0.00% |